Analyses of 2025 Medicare Advantage star ratings continue to pour in and not all of it bodes well for the conventional ...

The New York Nitro (7-1) and Miami Mayhem (5-3) are well positioned to qualify for the AVP League playoffs. The Palm Beach ...

Stock in the healthcare provider Humana came under pressure again on Friday after the U.S. government released quality ...

Humana HUM has outperformed the market over the past 15 years by 2.11% on an annualized basis producing an average annual ...

Twelve physician groups expressed their "profound objection" to Humana's classification of a spinal procedure as "unproven" in a letter to the healthcare insurer.

Our special guests Dr. Gail Rearden of Ochsner Novant Health 65 Plus and John Littig the President of the southeast region of ...

Clover Health (CLOV) stock gains and Humana (HUM) stock falls as the Centers for Medicare & Medicaid Services ...

Sixty-two percent of people currently enrolled in Medicare Advantage plans that cover prescription drugs are covered by plans ...

Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on Humana (HUM – Research Report) today and set a price target of $280.00. The company’s shares closed yesterday at $251.44. According to ...

A Tulsa woman says she received a message from Saint Francis that essentially states, change your doctor or change your ...